Syra Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-2.94	-2.12	-0
Depreciation & Amortization	0.05	0.11	0.03
Share-Based Compensation	0.03	0.51	0
Other Operating Activities	0.1	-0.75	-0.11
Operating Cash Flow	-2.76	-2.24	-0.09
Capital Expenditures	-0.02	-0.12	-0.01
Investing Cash Flow	-0.02	-0.12	-0.01
Share Issuance / Repurchase	5.33	2.32	0
Debt Issued / Paid	0.72	0.54	0.19
Other Financing Activities	-	-0.6	-
Financing Cash Flow	6.05	2.27	0.19
Net Cash Flow	3.28	-0.1	0.1
Free Cash Flow	-2.77	-2.37	-0.09
Free Cash Flow Margin	-50.30%	-42.10%	-6.70%
Free Cash Flow Per Share	-0.57	-0.78	-0.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).